Literature DB >> 5868263

Thalidomide malformations and genetic background in the rabbit.

P B Sawin, D Crary, R R Fox, H M Wuest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5868263     DOI： 10.1007/bf02144076

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  9 in total

1.  THE USE OF THALIDOMIDE AS TERATOGENIC AGENT IN RABBITS.

Authors:  A DEKKER; A MEHRIZI
Journal:  Bull Johns Hopkins Hosp       Date:  1964-09

2.  THALIDOMIDE EMBRYOPATHY IN HYBRID RABBITS.

Authors:  T H INGALLS; F J CURLEY; P ZAPPASODI
Journal:  N Engl J Med       Date:  1964-08-27       Impact factor: 91.245

3.  CONGENITAL MALFORMATIONS IN A THALIDOMIDE BABY: A POSTMORTEM ANATOMICAL STUDY.

Authors:  E O HAGEN
Journal:  Can Med Assoc J       Date:  1965-02-06       Impact factor: 8.262

4.  Thalidomide and congenital abnormalities.

Authors:  G S SOMERS
Journal:  Lancet       Date:  1962-04-28       Impact factor: 79.321

5.  [Observatios on the teratogenic repercussions of thalidomide in the mouse and rabbit].

Authors:  A GIROUD; H TUCHMANN-DUPLESSIS; L MERCIER-PAROT
Journal:  C R Seances Soc Biol Fil       Date:  1962

6.  [Thalidomide and abnormalities of development].

Authors:  G F SOMERS
Journal:  Orv Hetil       Date:  1962-12-30       Impact factor: 0.540

7.  [Malformations of the extremities. Research and treatment possibilities].

Authors:  E THISSEN
Journal:  Munch Med Wochenschr       Date:  1962-11-23

8.  Modified benzyl alcohol clearing of alizarinstained specimens without loss of flexibility.

Authors:  D D CRARY
Journal:  Stain Technol       Date:  1962-03

9.  Genetics of skeletal deformities in the domestic rabbit (Oryctolagus cuniculus).

Authors:  P B Sawin; D D Crary
Journal:  Clin Orthop Relat Res       Date:  1964 Mar-Apr       Impact factor: 4.176
  9 in total
  8 in total

1.  Hypervitaminosis A dysmelia in rats.

Authors:  A M Love; T H Vickers
Journal:  Br J Exp Pathol       Date:  1971-12

2.  The cardiovascular malformations in the rabbit thalidomide embryopathy.

Authors:  T H Vickers
Journal:  Br J Exp Pathol       Date:  1968-04

3.  Concerning the morphogeneis of thalidomide dysmelia in rabbits.

Authors:  T H Vickers
Journal:  Br J Exp Pathol       Date:  1967-12

4.  The alimentary tract malformations in the rabbit thalidomide embryopathy.

Authors:  T H Vickers
Journal:  Br J Exp Pathol       Date:  1970-06

5.  Relationship between teratogeny and structure in the thalidomide field.

Authors:  H M Wuest; R R Fox; D D Crary
Journal:  Experientia       Date:  1968-10-15

6.  Thalidomide induces limb anomalies by PTEN stabilization, Akt suppression, and stimulation of caspase-dependent cell death.

Authors:  Jürgen Knobloch; Ingo Schmitz; Katrin Götz; Klaus Schulze-Osthoff; Ulrich Rüther
Journal:  Mol Cell Biol       Date:  2008-01       Impact factor: 4.272

7.  Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice.

Authors:  Emma C Fink; Marie McConkey; Dylan N Adams; Saurav D Haldar; James A Kennedy; Andrew A Guirguis; Namrata D Udeshi; D R Mani; Michelle Chen; Brian Liddicoat; Tanya Svinkina; Andrew T Nguyen; Steven A Carr; Benjamin L Ebert
Journal:  Blood       Date:  2018-07-31       Impact factor: 25.476

8.  Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells.

Authors:  Kesavan Meganathan; Smita Jagtap; Vilas Wagh; Johannes Winkler; John Antonydas Gaspar; Diana Hildebrand; Maria Trusch; Karola Lehmann; Jürgen Hescheler; Hartmut Schlüter; Agapios Sachinidis
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.